News

CureVac and GSK settle mRNA patent dispute with Pfizer and BioNTech
Germany's CureVac and Britain's GSK have settled a years-long patent dispute with Pfizer and its partner BioNTech over the ...
Live Science on MSN9h
'These decisions were completely reckless': Funding cuts to mRNA vaccines will make America more vulnerable to pandemics
RNA expert Jeff Coller spoke with Live Science about the future of mRNA vaccines in the United States in the aftermath of ...
HHS slashes funding for mRNA vaccine development
US Health and Human Services is “winding down” its mRNA vaccine development and will instead fund other vaccine platforms ...
CureVac settles mRNA patent dispute litigation with Pfizer and BioNTech
(Reuters) -German drugmaker CureVac and GSK reached an agreement with BioNTech and Pfizer on Thursday to resolve a years-long ...
UPenn, where mRNA vaccine tech was pioneered, will not lose funding as feds cut $500M in mRNA grants
There have been no changes to the licensing and royalty agreements related to mRNA research that have netted the university ...
Moderna Announces Data to be Presented at ESMO Congress 2025
CAMBRIDGE, MA / ACCESS Newswire / July 28, 2025 / Moderna, Inc. (NASDAQ:MRNA) today announced that three abstracts on its ...
US rejection of mRNA vaccines shows ‘lack of respect for science,’ says Nobel laureate
The Nobel Prize winning scientist behind mRNA vaccine technology has attacked the US health secretary’s plan to effectively ...
BioSpace19h
Big Pharma-Backed mRNA Startup Bags $153M Series B Amid Policy Headwinds
Strand Therapeutics' lead asset is STX-001, an intra-tumor self-replicating mRNA therapy that carries a payload expressing ...